<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20221230056982N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-01-16</date_registration>
      <primary_sponsor>Oroumia University of Medical Sciences</primary_sponsor>
      <public_title>Evaluation of the effectiveness of the educational intervention of emotional regulation strategies  based on Gross model on emotion regulation strategies and psycho-social burden of women infected with human papillomavirus</public_title>
      <acronym></acronym>
      <scientific_title>Evaluation of the effectiveness of the educational intervention of emotional regulation strategies  based on Gross model on emotion regulation strategies and psycho-social burden of women infected with human papillomavirus</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-01-26</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>100</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/67728</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Single, Purpose: Education/Guidance, Randomization description: To select participants, the researcher will go to the specialized clinic of Kausar Medical Training Center in Urmia every day of the week. Among the clients of the clinic, women who meet the criteria for entering the study will be selected, then a brief explanation will be given to them about the goals and the work method. If there is no agreement, another person will be replaced. People will be randomly divided into two control groups (50 people) and intervention group (50 people). In this way, closed envelopes will be used for random allocation. Participants pick one envelope from among 100 envelopes in the box, 50 of which contain card "A" and the other 50 contain card "B". If they pick up the "A" card, they will be placed in the intervention group, and if they pick up the "B" card, they will be placed in the control group, Blinding description: The participants of the intervention group will be trained in 5 sessions of 45-60 minutes with a frequency of once a week, which are in the form of one-person classes, and to prevent the possibility of publishing information, the control group will be questioned first, so no one of the participants in the control and intervention groups will not be aware of the allocation of the study groups.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Human Papillomavirus.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: After obtaining the written consent, the demographic information questionnaire, the HIP questionnaire and the Gross Emotion Regulation Scale will be completed through self-reporting. The educational intervention will be carried out based on the educational protocol of Gross's emotional regulation strategies (individually). Participants of the intervention group will be trained in 5 sessions of 45 to 60 minutes with a frequency of once a week, which are in the form of one-on-one classes. In this intervention, educational aids such as PowerPoint, animation and brochures will be used. In the last session of the intervention and three months later, the questionnaires related to the post-test will be presented and completed again. Intervention 2: Control group: After obtaining the written consent, the demographic information questionnaire, the HIP questionnaire and the Gross Emotion Regulation Scale will be completed through self-reporting. No intervention will be done for this group. At the same time as the last intervention session and 3 months later, questionnaires related to the post-test will also be presented and completed for the control group. At the end of the study and after the completion of the training sessions, in order to maintain mental health and comply with ethical principles, a training session will be conducted for the participants of the control group and training content will be provided to them.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is there is no further information and the publication schedule of the article is not known.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr. Roghaye Bayrami</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Nursing and Midwifery, Pardis Nazlou, 11th km of Nazlou Highway, Urmia, Iran</address>
        <city>Urmia</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5756115335</zip>
        <telephone>+98 44 3223 4897</telephone>
        <email>Rozabayrami@yahoo.com</email>
        <affiliation>Oroumia University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr. Roghaye Bayrami</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Nursing and Midwifery, Pardis Nazlou, 11th km of Nazlou Highway, Urmia, Iran</address>
        <city>Urmia</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5756115335</zip>
        <telephone>+98 44 3223 4897</telephone>
        <email>Rozabayrami@yahoo.com</email>
        <affiliation>Oroumia University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Having written informed consent to participate in the study
age range of 15-49 years and married
The husband knowing that his wife is infected with HPV disease
The husband is infected with HPV disease
Having Iranian nationality
Being a resident of Urmia
Having at least fifth grade literacy
Definite diagnosis (by a gynecologist) during the last three months with HPV type
The absence of malignant diseases
Living with husband</inclusion_criteria>
      <agemin>15 years</agemin>
      <agemax>49 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Occurrence of pregnancy during the study
Unwillingness to cooperate in the continuation of the project
Not participating in more than two educational intervention sessions
Getting divorced and separated from the husband
Not having sex during life
Having an acute psychological incident such as losing a family member
Having mental illnesses such as severe depression and consuming addictive substances during the study and the last 6 months</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>B97.7</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Papillomavirus as the cause of diseases classified to other chapters</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Behavior</i_code>
      <i_code>Lifestyle</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: After obtaining the written consent, the demographic information questionnaire, the HIP questionnaire and the Gross Emotion Regulation Scale will be completed through self-reporting. The educational intervention will be carried out based on the educational protocol of Gross's emotional regulation strategies (individually). Participants of the intervention group will be trained in 5 sessions of 45 to 60 minutes with a frequency of once a week, which are in the form of one-on-one classes. In this intervention, educational aids such as PowerPoint, animation and brochures will be used. In the last session of the intervention and three months later, the questionnaires related to the post-test will be presented and completed again.</i_keyword>
      <i_keyword>Control group: After obtaining the written consent, the demographic information questionnaire, the HIP questionnaire and the Gross Emotion Regulation Scale will be completed through self-reporting. No intervention will be done for this group. At the same time as the last intervention session and 3 months later, questionnaires related to the post-test will also be presented and completed for the control group. At the end of the study and after the completion of the training sessions, in order to maintain mental health and comply with ethical principles, a training session will be conducted for the participants of the control group and training content will be provided to them.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>General psycho-social burden score of women infected with human papillomavirus. Timepoint: Measuring the general psycho-social burden score of infected women at the beginning of the study (before the start of the intervention) and 5 weeks later at the end of the last counseling session and 3 months later. Method of measurement: HIP questionnaire.</prim_outcome>
      <prim_outcome>Gross's emotional regulation strategies. Timepoint: Measurement of the Gross's emotional regulation strategies score of infected women at the beginning of the study (before the start of the intervention) and 5 weeks later at the end of the last counseling session and 3 months later. Method of measurement: Gross's emotion regulation questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Worries and concerns. Timepoint: Measurement of the Worries and concerns score of infected women at the beginning of the study (before the start of the intervention) and 5 weeks later at the end of the last counseling session and 3 months later. Method of measurement: HIP questionnaire.</sec_outcome>
      <sec_outcome>Emotional impact. Timepoint: Measurement of the emotional impact score of infected women at the beginning of the study (before the start of the intervention) and 5 weeks later at the end of the last counseling session and 3 months later. Method of measurement: HIP questionnaire.</sec_outcome>
      <sec_outcome>Sexual impact. Timepoint: Measurement of the sexual impact score of infected women at the beginning of the study (before the start of the intervention) and 5 weeks later at the end of the last counseling session and 3 months later. Method of measurement: HIP questionnaire.</sec_outcome>
      <sec_outcome>Self image. Timepoint: Measurement of the self image score of infected women at the beginning of the study (before the start of the intervention) and 5 weeks later at the end of the last counseling session and 3 months later. Method of measurement: HIP questionnaire.</sec_outcome>
      <sec_outcome>Partner and transmission. Timepoint: Measurement of the partner and transmission score of infected women at the beginning of the study (before the start of the intervention) and 5 weeks later at the end of the last counseling session and 3 months later. Method of measurement: HIP questionnaire.</sec_outcome>
      <sec_outcome>Interactions with doctors. Timepoint: Measurement of the interactions with doctors score of infected women at the beginning of the study (before the start of the intervention) and 5 weeks later at the end of the last counseling session and 3 months later. Method of measurement: HIP questionnaire.</sec_outcome>
      <sec_outcome>Control/life impact. Timepoint: Measurement of the control/life impact score of infected women at the beginning of the study (before the start of the intervention) and 5 weeks later at the end of the last counseling session and 3 months later. Method of measurement: HIP questionnaire.</sec_outcome>
      <sec_outcome>Cognitive reappraisal. Timepoint: Measurement of the cognitive reappraisal score of infected women at the beginning of the study (before the start of the intervention) and 5 weeks later at the end of the last counseling session and 3 months later. Method of measurement: Gross's emotion regulation questionnaire.</sec_outcome>
      <sec_outcome>Expressive suppression. Timepoint: Measurement of the expressive suppression score of infected women at the beginning of the study (before the start of the intervention) and 5 weeks later at the end of the last counseling session and 3 months later. Method of measurement: Gross's emotion regulation questionnaire.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Oroumia University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-12-03</approval_date>
        <contact_name>Ethics committee of Urmia University of Medical Sciences</contact_name>
        <contact_address>Urmia University Of Medical Sciences, Emergency Alley, Resalat Blvd., Urmia, Iran Urmia West Azarbaijan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
